The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study

SIMPLE SUMMARY: Diffuse large B-cell lymphoma (DLBCL) is a complex disease. A combination of immunotherapy and chemotherapy is used to treat DLBCL at initial diagnosis. Additional treatments are available when DLBCL does not respond to initial treatment; however, for many patients, DLBCL will stop r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zijlstra, Josée M., Follows, George, Casasnovas, Rene-Olivier, Vermaat, Joost S. P., Kalakonda, Nagesh, Choquet, Sylvain, Hill, Brian, Thieblemont, Catherine, Cavallo, Federica, la Cruz, Fatima De, Kuruvilla, John, Hamad, Nada, Jaeger, Ulrich, Caimi, Paolo, Gurion, Ronit, Warzocha, Krzysztof, Bakhshi, Sameer, Sancho, Juan-Manuel, Schuster, Michael, Egyed, Miklos, Offner, Fritz, Vassilakopoulos, Theodoros P., Samal, Priyanka, Ku, Matthew, Xu, Jenny, Corona, Kelly, Chamoun, Kamal, Shah, Jatin, Canales, Miguel, Maerevoet, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834328/
https://www.ncbi.nlm.nih.gov/pubmed/35159058
http://dx.doi.org/10.3390/cancers14030791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834328/
https://www.ncbi.nlm.nih.gov/pubmed/35159058
http://dx.doi.org/10.3390/cancers14030791

Ejemplares similares